Atlas Trials

Measles-Mumps-Rubella Vaccine

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Measles-Mumps-Rubella Vaccine

RecordFirmDate
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age (NCT02184572)GlaxoSmithKline2014-08-25
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life (NCT01681992)GlaxoSmithKline2012-10-10
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age (NCT00861744)GlaxoSmithKline2009-06-03

Track Measles-Mumps-Rubella Vaccine automatically

Every clearance here is in the API, with alerts when new ones post.